Vimian Group AB Logo

Vimian Group AB

Global animal health company in pharma, medtech, diagnostics, and vet services.

VIMIAN | ST

Overview

Corporate Details

ISIN(s):
SE0015961982 (+2 more)
LEI:
549300OQ8R5TCAP0BS18
Country:
Sweden
Address:
Riddargatan 19, 114 57 Stockholm

Description

Vimian Group is a global animal health company that applies science and technology to improve animal well-being. The company operates across four main segments: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Through its portfolio of businesses, Vimian develops, manufactures, and distributes a wide range of products and services, including pharmaceuticals, medical devices, diagnostic tools, and specialized veterinary care. Its growth strategy combines in-house research and development with the acquisition of innovative companies to expand its offerings for veterinary professionals, clinics, and laboratories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-30 17:30
Förändring av antalet aktier och röster i Vimian
Swedish 104.4 KB
2025-12-30 17:30
Change in the number of shares and votes in Vimian
English 104.1 KB
2025-12-22 21:30
Vimian har beslutat om nyemission och återköp av ytterligare D-aktier, E1 2025-…
Swedish 110.0 KB
2025-12-22 21:30
Vimian has resolved to issue and repurchase additional class D shares, class E1…
English 109.8 KB
2025-11-28 17:30
Change in the number of shares and votes in Vimian
English 106.5 KB
2025-11-28 17:30
Förändring av antalet aktier och röster i Vimian
Swedish 106.7 KB
2025-11-24 07:15
Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO
English 111.4 KB
2025-11-24 07:15
Vimian Group AB (publ) utser Alireza Tajbakhsh till vd och koncernchef
Swedish 111.3 KB
2025-10-27 07:00
Vimian has resolved to issue and repurchase class D shares, class E1 2025 share…
English 101.0 KB
2025-10-27 07:00
Vimian har beslutat om nyemission och återköp av D-aktier, E1 2025-aktier, E2 2…
Swedish 101.1 KB
2025-10-22 07:45 Swedish 2.0 MB
2025-10-22 07:45 English 1.9 MB
2025-09-23 10:00
Nomination Committee for Vimian’s 2026 Annual General Meeting
English 97.6 KB
2025-09-23 10:00
Valberedning inför Vimians årsstämma 2026
Swedish 97.6 KB
2025-08-30 01:03
Superior Court of Delaware awards Vimian USD 40.2 million in indemnification di…
English 108.1 KB

Automate Your Workflow. Get a real-time feed of all Vimian Group AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vimian Group AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vimian Group AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-14 Sven Johan Magnus Göte Kjellberg Other Sell 425,000 19,167,500.00 SEK
2024-12-23 Sven Johan Magnus Göte Kjellberg Other Sell 25,000 1,026,000.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.